Our Malady, by Timothy Snyder: book review
US Historian Timothy Snyder is expert for murderous totalitarian systems. Now, he himself almost died when he succumbed to the inhuman US profiteering industry which America calls healthcare.
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
US Historian Timothy Snyder is expert for murderous totalitarian systems. Now, he himself almost died when he succumbed to the inhuman US profiteering industry which America calls healthcare.
Star scientists Michel and Andre Nussenzweig come from a famous family of immunologists. Clare Francis looked at some of their papers.
Karin Dahlman-Wright, Karolinska Institute’s former president, then vice-president, now rector’s counsellor was found guilty of research misconduct, again. This time in 4 papers.
And then a Swedish court overturned everything and declared her innocent.
Erick Carreira’s letter to Guido, from 1996. You all saw it probably at some point, and now it’s being discussed again.
A review of “The Baltimore Case” by the historian Daniel Kelves and “Science Fictions” by the journalist John Crewdson, which also tell the history of the Office of Research Integrity (ORI).
Fake nanotechnology is always fun, but it does get extreme here. Word of advice: if you are in Turkey, better don’t point fingers at Professor Fatih Sen’s research. Things get broken easily.
Beware of Chinese collaborators bearing gift authorships!
Augustine Choi is Dean of Weill Cornell and a misunderstood genius. He discovered that carbon monoxide is a cure for all possible diseases, just add a bit of Photoshop.
The new book Adverse Events by Jill Fisher shows the reality behind phase 1 clinical trials in USA and the “healthy volunteers” who participate in those. Clue: they are not White middle-class university students with a penchant for altruism.
The University of Münster in Germany shows with a good example how to act on evidence of data manipulation. Neuroscientist Andreas Püschel has been found guilty of research misconduct. It was once again about a paper authored by his former PhD student and now Luxembourg stem cell researcher, Jens Schwamborn.









